Peter Goodhand

Investor

President (interim) at FACIT (Fight Against Cancer Innovation Trust)

Find your path to Peter

15 people in our graph can introduce you to Peter.

Paths you didn't know you had: your email and LinkedIn already hold routes to Peter. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Health innovation and commercialization executive with senior roles in the global medical technology industry across the UK, US, and Canada. Past President of OICR and former President and CEO of the Canadian Cancer Society; currently CEO of GA4GH.

Colleagues at FACIT (Fight Against Cancer Innovation Trust)

Connie Chen

Senior Director, Strategy and Corporate Development at FACIT (Fight Against Cancer Innovation Trust)

David Koehler

Director, Fund Operations at FACIT (Fight Against Cancer Innovation Trust)

David O'Neill

President at FACIT (Fight Against Cancer Innovation Trust)

Elizabeth Douville

Investment Committee Chair at FACIT (Fight Against Cancer Innovation Trust)

Enrico D'Angelo

CFO at Parkwalk Advisors

Francesca Chappell

Chief Finance Officer at BP Marsh & Partners PLC

Kelly Holman

Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)

Ken Newport

Board Director at FACIT (Fight Against Cancer Innovation Trust)

Frequently asked questions

Who is Peter Goodhand?: Health innovation and commercialization executive with senior roles in the global medical technology industry across the UK, US, and Canada. Past President of OICR and former President and CEO of the Canadian Cancer Society; currently CEO of GA4GH.
Where does Peter Goodhand work?: Peter Goodhand is President (interim) at FACIT (Fight Against Cancer Innovation Trust).